bpc-157 caffeine pouch use by young people raises new concerns BPC-157: Experimental Peptide Creates Risk

Recent studies have demonstrated that primary and secondary sites can communicate through exosomes, shed not only by the primary tumor cells, but also by the immune and stromal cells such as NK cells, CAFs and dendritic cells [19]

A ratio that favors BDNF could signal positive neuroplasticity/neuroprotection (i.e., during adolescence and young adulthood) [22]

For surgical applications and post-operative recovery, BPC-157's effects on wound healing, anastomosis strength, and tissue integration suggest potential perioperative applications

In addition, Zealand and Roche are developing petrelintide as standalone treatment and in combinations, including a program with Roche's incretin candidate CT-388